Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Sublingual tizanidine 12 mg
(D08611)		1件: Tizanidine1件: Tizanidine (D08611) 💬3件: ADRA2A,
ADRA2B,
ADRA2C 💬		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 13 💬
2Tizanidine
(D08611)		1件: Tizanidine1件: Tizanidine (D08611) 💬3件: ADRA2A,
ADRA2B,
ADRA2C 💬		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 13 💬
3Tizanidine (sublingual or oral)
(D08611)		1件: Tizanidine1件: Tizanidine (D08611) 💬3件: ADRA2A,
ADRA2B,
ADRA2C 💬		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 13 💬
4Tizanidine hydrochloride capsule
(D08611)		1件: Tizanidine1件: Tizanidine (D08611) 💬3件: ADRA2A,
ADRA2B,
ADRA2C 💬		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 13 💬